N-[3-(methylamino)propyl]oxolane-2-carboxamide

We are N-[3-(methylamino)propyl]oxolane-2-carboxamide CAS:81403-67-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  N-[3-(methylamino)propyl]oxolane-2-carboxamide
CAS.NO:81403-67-0
Synonyms:
Tetrahydrofuran-2-carboxylic acid (3-methylaminopropyl)amide
N-<3-(methylamino)propyl>tetrahydrofuran-2-carboxamide
tetrahydro-N-<3-(methylamino)propyl>-furancarboxamide
N1-methyl-N2-tetrahydrofuroylpropylenediamine
N-[3-(methylamino)propyl]-2-oxolanecarboxamide

Molecular Formula:C9H18N2O2
Molecular Weight: 186.25100

Physical and Chemical Properties:
Density:1.045 g/cm3
Boiling point: 380.81ºC at 760 mmHg
Melting point:/
Flash point:184.108ºC
Refractive index: 1.477

Specification:
Appearance:/
Purity:≥97%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage: Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:
Intermediates of Alfuzosin hydrochloride CAS: 81403-68-1

N-[3-(methylamino)propyl]oxolane-2-carboxamide


Related News: Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.Cyanoacetic acid The increase in environmental protection pressure has also increased the environmental protection expenditure of pharmaceutical manufacturing companies, which forced some small production capacity to withdraw from the market, increased industry concentration, and brought certain opportunities for API manufacturers.(6S)​-​5-​Azaspiro[2.4]​heptane-​5,​6-​dicarboxylic acid 5-​(1,​1-​dimethylethyl) ester potassium salt In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the “Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry”, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. .9- (4-broMofenil) -10- (naftalen-1-il) antraceno CAS:1160506-32-0 Characteristic APIs are usually more complex in structure, and their synthesis involves a variety of technologies such as chiral synthesis, green synthesis, and catalysis, which requires high research and development capabilities in the production process of API companies.Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development.

Related Products
Product Name
4-Aminobenzotrifluoride View Details
4-CHLORO-2-FLUORO-5-NITROBENZOIC ACID View Details
Ethyl 3-[[3-amino-4-(methylamino)benzoyl]-pyridin-2-ylamino]propanoate View Details
5-methoxybenzo[b][1]benzazepine-11-carbonyl chloride manufacturer Methyl 6-fluoro-1H-indole-4-carboxylate manufacturer 4-aminobenzamide manufacturer Ethylurea manufacturer 1-Methyl-3-phenylpiperazine manufacturer